US vaccines are on the rise as feeds weigh the 2nd COVID-19 shot

WASHINGTON (AP) – Hundreds of U.S. hospitals will begin vaccinating their workers on Tuesday as federal health officials consider the second Govt-19 shot needed to boost the nation’s largest vaccination campaign.

Filled with dry ice to withstand extreme freezing temperatures, Pfizer’s COVID-19 vaccine is due to arrive at 400 additional hospitals and other distribution sites, a day after the nation’s death toll topped 300,000. The first 3 million shots are definitely estimated Leading U.S. health workers and geriatric patients need hundreds of millions of shots in the coming months to protect most Americans.

The Food and Drug Administration is about to release its analysis of the second COVID-19 vaccine, which has been closely studied, and may soon join Pfizer-Bioentech. In the fight against infection. If FDA advisers make a positive recommendation Thursday, the agency could greenlight the vaccine from drug maker Moderna this weekend.

Based on weekly averages from data compiled by Johns Hopkins University, the country’s daily death toll of more than 2,400 out of 210,000 new daily cases is not coming soon. The catastrophic number is expected to increase only in the coming weeks, triggered by holiday travel, family reunions and adherence to basic public health activities.

Ratio
YouTube video thumbnail

First vaccine distribution It has provided incentives across the country for exhausted doctors, nurses and hospital staff.

Johnny Peoples, a 43-year-old surviving flight attendant, became the first person to be vaccinated at the University of Michigan Medical Center after unbuttoning his aerial suit on Monday afternoon. Ann Arbor.

“It’s a good feeling to be a part of it,” he said.

Since March, he has been transporting sick COVID-19 patients by jet from small hospitals across the state to the University Medical Center. This is a very intimate and personal job that requires adjusting the ventilator systems and managing the infusions to keep the blood pressure from falling.

In Florida, government officials expect state hospitals to vaccinate 100,000 doses by Tuesday.

John Corys, president and CEO of Tampa General Hospital, said after delivering 3,900 vials of vaccine on Monday, “This is a 20,000 level of confidence. Each vial has five sizes.

Because the vaccine requires two rounds, individuals who inject now will need a second shot in about three weeks.

Vaccines are expected to be kicked off Tuesday in New Jersey, which separates approximately 76,000 doses between health care workers and nursing home residents. The Central Government is coordinating the massive distribution activity of private shipping and distribution companies based on the locations selected by the State Governors.

Following another initial distribution on Wednesday, officials with the Trump administration’s Operation Warp Speed ​​in Washington said they would begin moving another 580 exports over the weekend.

“We are starting our drum beat to continue implementing the vaccine as it becomes available,” Warp Speed ​​chief operating officer General Gustav Berna told reporters Monday. “We compile, we deliver. This is a steady stream of available vaccines.”

Screenings for nursing home residents will not begin in most states until the 1,100 facilities start vaccinating next Monday.

Berna and other U.S. officials reiterated the plan that by the end of December, 20 million Americans will have their first footage and 30 million by January.

The program considers rapid approval for the vaccine this week, developed jointly by Moderna and the National Institutes of Health. Like the Pfizer-Bioentech vaccine, Moderna requires two shots for complete protection.

Last month, Moderna and the NIH reported that their shot was nearly 95% effective among people of different ages and ethnicities, according to the results of a study of 30,000 older people. The main side effects after the second side were fatigue, muscle pain and injection-site pain. Influenza-like reactions are common to many vaccines and are a sign that the vaccine is renewing the immune system to help fight the virus.

Moderna did not report any major security issues from its study. But the FDA team is sure to examine the data for signs of severe allergic reactions or other rare side effects. UK authorities are investigating several adverse reactions to Pfizer’s vaccine, and the FDA is closely monitoring browsing here for similar reports.

Both Moderna and Pfizer-Bioentech shots are called MRNA vaccines, A new technology. They are not created by the corona virus, which means no one is likely to catch it from the shots. Instead, the vaccine contains a portion of the genetic code that trains the immune system to recognize the sharp protein on the surface of the virus.

___

Associated Press writers Lindsay Tanner, Tamara Lush, Candice Choi and Lauren Neergard contributed to the report.

___

The Associated Press Department of Health and Science is supported by the Department of Science Education at Howard Hughes Medical Institute. AP is solely responsible for all content.

.Source

Leave a Comment